Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment

• Status: Completed
• Trial end date: 2020-08-10
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to assess the efficacy of Dexmedetomidine drug either used sublingually or intranasally in managing healthy children during dental treatment

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nourhan M.Aly
• Collaborator: Alexandria University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• Frankl behavior rating score 2.

• ASA I physical status.

• Dental intervention under local anesthesia not requiring more than 30 minutes.

• No previous dental experience.

• Parent/guardian written consent.

Exclusion Criteria:

• Dental treatment indicated requiring general anesthesia.

• Mouth breathers.

• Patients with acute upper respiratory illness.

• Medically compromised patients.

• Cognitively impaired patients.